Cargando…
Potential biomarker identification for Friedreich’s ataxia using overlapping gene expression patterns in patient cells and mouse dorsal root ganglion
Friedreich’s ataxia (FA) is a neurodegenerative disease with no approved therapy that is the result of frataxin deficiency. The identification of human FA blood biomarkers related to disease severity and neuro-pathomechanism could support clinical trials of drug efficacy. To try to identify human bi...
Autores principales: | McMackin, Marissa Z., Durbin-Johnson, Blythe, Napierala, Marek, Napierala, Jill S., Ruiz, Luis, Napoli, Eleonora, Perlman, Susan, Giulivi, Cecilia, Cortopassi, Gino A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821053/ https://www.ncbi.nlm.nih.gov/pubmed/31665133 http://dx.doi.org/10.1371/journal.pone.0223209 |
Ejemplares similares
-
Friedreich's ataxia – a case of aberrant transcription termination?
por: Butler, Jill Sergesketter, et al.
Publicado: (2015) -
Dyclonine rescues frataxin deficiency in animal models and buccal cells of patients with Friedreich's ataxia
por: Sahdeo, Sunil, et al.
Publicado: (2014) -
Somatic instability of the expanded GAA repeats in Friedreich’s ataxia
por: Long, Ashlee, et al.
Publicado: (2017) -
Selected missense mutations impair frataxin processing in Friedreich ataxia
por: Clark, Elisia, et al.
Publicado: (2017) -
Understanding the genetic and molecular pathogenesis of Friedreich’s ataxia through animal and cellular models
por: Martelli, Alain, et al.
Publicado: (2012)